Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
6%
Age of Onset
10%
Aging Effect
10%
Authorship Criteria
10%
Cardiovascular History
10%
Cardiovascular Risk
10%
Clinical Data
13%
Clinical Decision Support Tool
10%
Clinical Phenotype
10%
Cross-cohort
10%
Cross-sectional Observational Study
10%
Disease Duration
10%
Disease Effects
10%
Dopaminergic Pathway
10%
Family History
5%
Gait Data
10%
GBA1
11%
Gut Microbiota
10%
Health Effects
10%
Healthy Controls
6%
History of Cardiovascular Disease
5%
Idiopathic Parkinson's Disease
21%
Idiopathic PD
10%
Levodopa-induced Dyskinesia
21%
Long-read Sequencing
10%
Luxembourg
5%
Luxembourgish
11%
Machine Learning
13%
Major Risk
10%
Memory Impairment
10%
Metabolomics Data
10%
Mild Cognitive Impairment
21%
Non-carriers
5%
Outcome Prediction
10%
Parkinson
25%
Parkinson Patients
5%
Parkinson's Disease
64%
Parkinson's Disease-mild Cognitive Impairment
6%
Pathogenic Variants
5%
Polygenic Background
10%
Polygenic Risk Score
13%
Post-COVID
10%
Predictors of Cognitive Impairment
10%
Prognostic Analysis
10%
Risk Factors
12%
Risk Variant
10%
Variant Carriers
10%
Xanthine Metabolism
10%
Neuroscience
Cardiovascular System
10%
Cognitive Disorders
11%
Comorbidity
13%
Dopamine
10%
Dyskinesia
21%
Gait
10%
Gut Microbiome
21%
L-DOPA
21%
Memory Disorder
10%
MicroRNA
10%
Mild Cognitive Impairment
34%
Parkinson's Disease
100%
Polygenic Risk Score
13%
Progressive Supranuclear Palsy
10%
Risk Factor
16%
SARS Coronavirus
5%
Subjective Cognitive Decline
5%
Medicine and Dentistry
Cardiovascular Disease
6%
Cardiovascular System
10%
Comorbidity
8%
Dopamine
10%
Education
10%
Gait
24%
Gut Microbiome
10%
Levodopa-Induced Dyskinesia
10%
Metabolomics
21%
Mild Cognitive Impairment
10%
Observational Study
10%
Parkinson's Disease
52%
Stereotypic Movement Disorder
5%
